Metis Global Partners LLC Raises Position in HCA Healthcare, Inc. (NYSE:HCA)

Metis Global Partners LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 18.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,939 shares of the company’s stock after purchasing an additional 1,379 shares during the quarter. Metis Global Partners LLC’s holdings in HCA Healthcare were worth $2,199,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Jump Financial LLC lifted its stake in shares of HCA Healthcare by 885.1% during the 3rd quarter. Jump Financial LLC now owns 7,280 shares of the company’s stock worth $1,791,000 after purchasing an additional 6,541 shares during the period. Hedeker Wealth LLC raised its position in shares of HCA Healthcare by 18.5% in the 3rd quarter. Hedeker Wealth LLC now owns 11,382 shares of the company’s stock worth $2,800,000 after buying an additional 1,780 shares during the period. abrdn plc raised its position in shares of HCA Healthcare by 4.8% in the 3rd quarter. abrdn plc now owns 164,419 shares of the company’s stock worth $40,444,000 after buying an additional 7,476 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its position in shares of HCA Healthcare by 6.3% in the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 185,813 shares of the company’s stock worth $45,706,000 after buying an additional 10,959 shares during the period. Finally, Sivik Global Healthcare LLC raised its position in shares of HCA Healthcare by 60.0% in the 3rd quarter. Sivik Global Healthcare LLC now owns 40,000 shares of the company’s stock worth $9,839,000 after buying an additional 15,000 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on HCA. Mizuho lowered their price target on HCA Healthcare from $325.00 to $275.00 and set a “buy” rating for the company in a report on Wednesday, October 25th. Oppenheimer reissued an “outperform” rating and set a $315.00 target price on shares of HCA Healthcare in a report on Wednesday, January 17th. Truist Financial dropped their target price on HCA Healthcare from $340.00 to $300.00 and set a “buy” rating on the stock in a report on Wednesday, October 25th. JPMorgan Chase & Co. dropped their target price on HCA Healthcare from $313.00 to $265.00 and set a “neutral” rating on the stock in a report on Friday, November 17th. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Wednesday, November 1st. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $299.89.

Read Our Latest Analysis on HCA Healthcare

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $301.52 on Wednesday. The company’s fifty day moving average is $270.24 and its two-hundred day moving average is $261.63. The company has a quick ratio of 0.99, a current ratio of 1.15 and a debt-to-equity ratio of 103.06. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $304.95. The company has a market cap of $80.70 billion, a P/E ratio of 14.83, a price-to-earnings-growth ratio of 1.53 and a beta of 1.65.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.05 by $0.85. HCA Healthcare had a net margin of 9.05% and a return on equity of 2,040.32%. The company had revenue of $17.30 billion for the quarter, compared to the consensus estimate of $16.51 billion. During the same period in the previous year, the business earned $4.64 EPS. The company’s revenue was up 11.7% on a year-over-year basis. Equities analysts expect that HCA Healthcare, Inc. will post 18.2 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Friday, March 15th will be issued a dividend of $0.66 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a dividend yield of 0.88%. HCA Healthcare’s payout ratio is currently 11.81%.

HCA Healthcare declared that its board has approved a stock repurchase plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 7.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its stock is undervalued.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.